Stockscreener 앱 받기
2.77
2.11%
-0.07
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Orchestra BioMed shares surge on FDA breakthrough designation - Investing.com Australia
FDA grants breakthrough status to Orchestra BioMed’s AVIM therapy - Investing.com
Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation Therapy to Address Uncontrolled Hypertension - Nasdaq
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy - GlobeNewswire
Orchestra BioMed (OBIO) Receives FDA Breakthrough Device Designation for AVIM Therapy - StreetInsider
Orchestra's Revolutionary Blood Pressure Device Earns FDA Breakthrough Status: 7.7M Patients Could Benefit - Stock Titan
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy - MSN
Orchestra BioMed’s Strategic Advances in Medical Innovations - TipRanks
What is B. Riley’s Estimate for OBIO Q1 Earnings? - Defense World
Chardan Capital Has Strong Outlook for OBIO FY2025 Earnings - Defense World
Orchestra BioMed (NASDAQ:OBIO) Upgraded at B. Riley - Defense World
HC Wainwright Has Lowered Expectations for Orchestra BioMed (NASDAQ:OBIO) Stock Price - Defense World
H.C. Wainwright cuts Orchestra BioMed stock target to $12 By Investing.com - Investing.com Australia
Where Orchestra BioMed Hldgs Stands With Analysts - Benzinga
Health Check: How Prudently Does Orchestra BioMed Holdings (NASDAQ:OBIO) Use Debt? - simplywall.st
HighTower Advisors LLC Has $274,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from Chardan Capital - Defense World
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Orchestra BioMed (NASDAQ:OBIO) Posts Earnings Results, Hits Estimates - MarketBeat
BTIG maintains $12 target on Orchestra BioMed stock By Investing.com - Investing.com Canada
BTIG maintains $12 target on Orchestra BioMed stock - Investing.com Australia
OBIO stock touches 52-week low at $3.63 amid market challenges By Investing.com - Investing.com South Africa
OBIO stock touches 52-week low at $3.63 amid market challenges - Investing.com Australia
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update - The Manila Times
Orchestra BioMed Secures $30M Funding While Advancing Key Clinical Trials Despite Wider Losses - Stock Titan
(OBIO) Trading Advice - news.stocktradersdaily.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Freightos And 2 Other Penny Stocks Worth Watching - simplywall.st
Orchestra BioMed (NASDAQ:OBIO) Research Coverage Started at BTIG Research - ETF Daily News
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated at BTIG Research - The AM Reporter
BTIG Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - Nasdaq
BTIG sets Orchestra BioMed stock with $12 target By Investing.com - Investing.com Australia
Insiders In Orchestra BioMed Holdings Left Out From 10% Price Rise After Disposing Stock - simplywall.st
BTIG Initiates Orchestra BioMed at Buy With $12 Price Target -March 20, 2025 at 07:15 am EDT - Marketscreener.com
Orchestra BioMed (OBIO) Projected to Post Earnings on Wednesday - Defense World
Orchestra BioMed (NASDAQ:OBIO) Given Buy Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $14 target on Orchestra BioMed stock By Investing.com - Investing.com South Africa
Promising Clinical Developments and Strategic Advancements Drive Buy Rating for Orchestra BioMed Holdings - TipRanks
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study - MSN
Orchestra BioMed Highlights Strategic Initiatives and Innovations - TipRanks
Orchestra BioMed to Participate in Upcoming Investor Conferences - MSN
Orchestra BioMed Updates Executive Compensation Policies - TipRanks
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN
Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewswire
1.75%
2.22%
자본화:
|
볼륨(24시간):